Table 1 Comparison of baseline data between the recruited groups.

From: Preliminary observational study of metabonomics in patients with early and late-onset type 2 diabetes mellitus based on UPLC-Q-TOF/MS

Items

EarT2DM (n = 21)

HeaCG1 (n = 25)

LatT2DM (n = 48)

HeaCG2 (n = 23)

P-value EarT2DM vs HeaCG1

P-value LatT2DM vs HeaCG2

Age (years)

34.0 ± 4.2

35.2 ± 5.3

58.9 ± 5.9

58.4 ± 9.0

0.384

0.796

Tg (mmol/l)

2.42 ± 0.65

1.87 ± 0.91

2.36 ± 1.02

1.83 ± 0.78

0.026

0.034

Tc (mmol/l)

5.02 ± 1.06

4.94 ± 0.68

5.38 ± 1.29

5.11 ± 0.89

0.765

0.383

HDL-c (mmol/l)

1.21 ± 0.45

1.20 ± 0.29

1.10 ± 0.28

1.32 ± 0.36

0.960

0.012

LDL-c (mmol/l)

3.31 ± 0.88

3.25 ± 0.81

3.51 ± 1.11

3.43 ± 0.85

0.813

0.772

Weight (kg)

81.9 ± 12.8

73.6 ± 13.4

81.0 ± 10.3

74.6 ± 16.6

0.037

0.045

BMI (kg/m2)

28.9 ± 3.5

25.7 ± 5.6

27.5 ± 4.1

25.2 ± 4.2

0.026

0.025

  1. EarT2DM Early-onset T2DM, HeaCG1 Healthy Control Group 1, LatT2DM Late-onset T2DM, HeaCG2 Healthy Control Group 2, Tg triglyceride, Tc total cholesterol, HDL-c high-density cholesterol, LDL-c low-density cholesterol, BMI body mass index.
Back to article page